These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19824823)

  • 1. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats.
    Cai J; Yang M; Poremsky E; Kidd S; Schneider JS; Iacovitti L
    Stem Cells Dev; 2010 Jul; 19(7):1017-23. PubMed ID: 19824823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
    Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
    Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
    Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
    Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease.
    Shrigley S; Nilsson F; Mattsson B; Fiorenzano A; Mudannayake J; Bruzelius A; Ottosson DR; Björklund A; Hoban DB; Parmar M
    J Parkinsons Dis; 2021; 11(2):515-528. PubMed ID: 33361611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
    Studer L
    Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo.
    Wakeman DR; Hiller BM; Marmion DJ; McMahon CW; Corbett GT; Mangan KP; Ma J; Little LE; Xie Z; Perez-Rosello T; Guzman JN; Surmeier DJ; Kordower JH
    Stem Cell Reports; 2017 Jul; 9(1):149-161. PubMed ID: 28579395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo.
    Iacovitti L; Donaldson AE; Marshall CE; Suon S; Yang M
    Brain Res; 2007 Jan; 1127(1):19-25. PubMed ID: 17123482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amniotic fluid stem cells do not differentiate into dopamine neurons in vitro or after transplantation in vivo.
    Donaldson AE; Cai J; Yang M; Iacovitti L
    Stem Cells Dev; 2009 Sep; 18(7):1003-12. PubMed ID: 19049321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Exp Neurol; 2008 Apr; 210(2):608-23. PubMed ID: 18272152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons.
    Xue Y; Zhan X; Sun S; Karuppagounder SS; Xia S; Dawson VL; Dawson TM; Laterra J; Zhang J; Ying M
    Stem Cells Transl Med; 2019 Feb; 8(2):112-123. PubMed ID: 30387318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ES cell-derived renewable and functional midbrain dopaminergic progenitors.
    Chung S; Moon JI; Leung A; Aldrich D; Lukianov S; Kitayama Y; Park S; Li Y; Bolshakov VY; Lamonerie T; Kim KS
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9703-8. PubMed ID: 21606375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease.
    Zheng X; Han D; Liu W; Wang X; Pan N; Wang Y; Chen Z
    Theranostics; 2023; 13(8):2673-2692. PubMed ID: 37215566
    [No Abstract]   [Full Text] [Related]  

  • 15. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.
    Bjorklund LM; Sánchez-Pernaute R; Chung S; Andersson T; Chen IY; McNaught KS; Brownell AL; Jenkins BG; Wahlestedt C; Kim KS; Isacson O
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2344-9. PubMed ID: 11782534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells.
    Li H; Jiang H; Li H; Li L; Yan Z; Feng J
    Mol Psychiatry; 2022 Nov; 27(11):4407-4418. PubMed ID: 35610351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.
    Wang M; Ling KH; Tan JJ; Lu CB
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application.
    Hiramatsu S; Morizane A; Kikuchi T; Doi D; Yoshida K; Takahashi J
    J Parkinsons Dis; 2022; 12(3):871-884. PubMed ID: 34958047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.